Human papillomavirus and cervical disease prevention
Region Stockholm supports clinical research focused on HPV infection and its associated conditions, including cervical intraepithelial neoplasia and cervical cancer. The funded work is centered on prevention and early detection within the cervical screening pathway.
- HPV vaccination
- HPV screening
- Cervical intraepithelial neoplasia grade 2 and 3
- Cervical cancer
The research activity is linked to population-level strategies for reducing persistent HPV circulation and improving prevention of cervical malignancy in women eligible for organised screening.
Population-based women’s health screening
The sponsor’s clinical research interest includes organised screening programmes for women in the target age group, with attention to integrating preventive services into routine public health care. The emphasis is on accessible, population-wide delivery of cervical screening and vaccination.
- Women aged 23-25 years
- Organised cervical screening
- Preventive women’s health
- Population-level elimination strategies
This area reflects interest in coordinated public health interventions that combine prevention and screening within the Swedish health care setting.
